165
Participants
Start Date
April 30, 2002
Study Completion Date
October 31, 2002
Protease inhibitor tipranavir
Mount Sinai School of Medicine, New York
University of New York at Stony Brook, Stony Brook
Albany Medical College, Albany
Georgetown University Medical Center, Washington D.C.
Dupont Circle Physicians Group, Washington D.C.
John's Hopkins University School of Medicine, Baltimore
Infectious Disease Physicians Research, Annandale
Wake Forest University Baptist Medical Center, Winston-Salem
University of North Carolina, Chapel Hill
Duke University Medical Center Infectious Diseases Clinic, Durham
Jemsek Clinic, Huntersville
Burnside Clinic, Columbia
Atlanta VA Medical Center, Dept. of ID, Decatur
AIDS Research Consortium of Atlanta, Atlanta
Mercer University School of Medicine, Macon
(IDC) Research Institute, Altamonte Springs
Treasure Coast Infectious Disease Consultants, Vero Beach
Steinhart Medical Associates, South Miami
Jackson Medical Tower, Miami
Therafirst Medical Center, Fort Lauderdale
Hillsborough County Health Dept., Tampa
Vanderbilt University - AIDS Clinical Trial Unit, Nashville
University of Louisville, Louisville
Ohio State University Medical Center, Columbus
University of Michigan Health System, Ann Arbor
Henry Ford Hospital, Infectious Diseases Dept., Detroit
CORE Center, Cook County Hospital, Chicago
Rush Presbyterian/St. Luke's Medical Center, Chicago
Washington University AIDS Clinical Trial Unit, St Louis
Kansas City Free Health Clinic, Kansas City
HIV Outpatient Program (H.O.P.), New Orleans
Infect. Disease Institute, Clinical Trials Unit, Oklahoma City
Nelson-Tebedo Clinic, Dallas
Gathe Clinic, Houston
Phoenix Body Positive, Phoenix
Wellness Center, Las Vegas
AHF Research Center, Los Angeles
University of So. California / LA County USC Medical Center, Los Angeles
ID Care, Inc., Los Angeles
Tower I.D. Medical Assoc., Inc., Los Angeles
University of California, Los Angeles Medical Center, Los Angeles
Living Hope Clinical Trials Inc., Long Beach
Orange County Center for Special Immunology, Fountain Valley
University of California San Francisco Positive Health Program Research, San Francisco
Pacific Horizon Medial Group, San Francisco
Southwest CARE Center, Santa Fe
Community Research Initiative of New England, Boston
CRI Community Research Initiative, Springfield
ID Care, Inc., Hillsborough
ID Care, Inc., Randolph Township
Clinical Research Puerto Rico, San Juan
Lead Sponsor
Boehringer Ingelheim
INDUSTRY